A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cells

被引:23
作者
Chamarthy, SP
Kovacs, JR
McClelland, E
Gattens, D
Meng, WS
机构
[1] Duquesne Univ, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA
[2] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA
关键词
genetic immunization; dendritic cells; non-viral gene delivery; poly-L-lysine; poly-L-ornithine;
D O I
10.1016/j.molimm.2003.08.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Condensing the plasmid with high molecular weight cationic polymers such as poly-L-lysine (PLL) and poly-L-ornithine (PLO) can enhance antigen-specific immunity generated from genetic vaccination with naked DNA encoding antigens. While these high molecular weight polymers are clearly effective in transfection experiments, clinical applications are limited by their physical heterogeneity and toxicity. Three chemically defined low molecular weight cationic peptides, K-16, K10H6, and O10H6, were examined in the context of DNA binding, toxicity, and efficiency of gene transfer in dendritic cells (DC). The results showed that while all three peptides can bind to a plasmid encoding a reporter gene with similar efficiency, in vitro transfection with DNA complexed with O10H6 complexed resulted in the highest level of gene expression. Moreover, free O10H6 was not toxic to DC, while the lysine-based peptides caused significant cell death in DC cultures. We also showed that DC transfected ex vivo with DNA complexed with O10H6 was capable of eliciting antigen-specific INFgamma production in vivo. Taken together, these results indicate ornithine and histidine repeats are suitable building blocks of non-viral gene transfer vector for DC. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 55 条
[1]   Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes [J].
Barron, LG ;
Uyechi, LS ;
Szoka, FC .
GENE THERAPY, 1999, 6 (06) :1179-1183
[2]   GENE-TRANSFER WITH SYNTHETIC CATIONIC AMPHIPHILES - PROSPECTS FOR GENE-THERAPY [J].
BEHR, JP .
BIOCONJUGATE CHEMISTRY, 1994, 5 (05) :382-389
[3]  
Butz EA, 1998, J IMMUNOL, V160, P2139
[4]   DNA-based vaccines for the treatment of cancer - an experimental model [J].
Cohen, EP .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (04) :175-179
[5]   FACILITATED DNA INOCULATION INDUCES ANTI-HIV-1 IMMUNITY IN-VIVO [J].
CONEY, L ;
WANG, B ;
UGEN, KE ;
BOYER, J ;
MCCALLUS, D ;
SRIKANTAN, V ;
AGADJANYAN, M ;
PACHUK, CJ ;
HEROLD, K ;
MERVA, M ;
GILBERT, L ;
DENG, KS ;
MOELLING, K ;
NEWMAN, M ;
WILLIAMS, WV ;
WEINER, DB .
VACCINE, 1994, 12 (16) :1545-1550
[6]   PLASMID DNA IS SUPERIOR TO VIRAL VECTORS FOR DIRECT GENE-TRANSFER INTO ADULT-MOUSE SKELETAL-MUSCLE [J].
DAVIS, HL ;
DEMENEIX, BA ;
QUANTIN, B ;
COULOMBE, J ;
WHALEN, RG .
HUMAN GENE THERAPY, 1993, 4 (06) :733-740
[7]   DNA VACCINES - PROTECTIVE IMMUNIZATIONS BY PARENTERAL, MUCOSAL, AND GENE-GUN INOCULATIONS [J].
FYNAN, EF ;
WEBSTER, RG ;
FULLER, DH ;
HAYNES, JR ;
SANTORO, JC ;
ROBINSON, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11478-11482
[8]   Intracellular processing and stability of DNA complexed with histidylated polylysine conjugates [J].
Gonçalves, C ;
Pichon, C ;
Guérin, B ;
Midoux, P .
JOURNAL OF GENE MEDICINE, 2002, 4 (03) :271-281
[9]  
Gottschalk S, 1996, GENE THER, V3, P448
[10]  
Gregoriadis G, 1999, CURR OPIN MOL THER, V1, P39